-
Loading metrics
Open Access
Peer-reviewed
Research Article
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets
-
Humaira Rasheed,
Affiliations Department of Biochemistry, University of Otago, Dunedin, New Zealand, University of Engineering and Technology, Lahore, Pakistan
⨯ -
Cushla McKinney,
Affiliation Department of Biochemistry, University of Otago, Dunedin, New Zealand
⨯ -
Lisa K. Stamp,
Affiliation Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand
⨯ -
Nicola Dalbeth,
Affiliation Department of Medicine, University of Auckland, Auckland, New Zealand
⨯ -
Ruth K. Topless,
Affiliation Department of Biochemistry, University of Otago, Dunedin, New Zealand
⨯ -
Richard Day,
Affiliations School of Medical Sciences, University of New South Wales, Sydney, Australia, Department of Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Sydney, Australia
⨯ -
Diluk Kannangara,
Affiliations School of Medical Sciences, University of New South Wales, Sydney, Australia, Department of Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Sydney, Australia
⨯ -
Kenneth Williams,
Affiliations School of Medical Sciences, University of New South Wales, Sydney, Australia, Department of Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Sydney, Australia
⨯ -
Malcolm Smith,
Affiliation Department of Medicine, Flinders Medical Centre and Repatriation General Hospital, Adelaide, Australia
⨯ -
Matthijs Janssen,
Affiliation Department of Rheumatology, Rijnstate Hospital, Arnhem, The Netherlands
⨯ -
Tim L. Jansen,
Affiliation Department of IQ HealthCare, VieCuri Medical Centre, Venlo, The Netherlands
⨯ -
Leo A. Joosten,
Affiliation Department of Internal Medicine and Radboud Institute of Molecular Life Science, Radboud University Medical Center, Nijmegen, The Netherlands
⨯ -
Timothy R. Radstake,
Affiliation Department of Rheumatology and Clinical Immunology, Laboratory of Translational Immunology, Department of Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands
⨯ -
Philip L. Riches,
Affiliation Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
⨯ -
Anne-Kathrin Tausche,
Affiliation Department of Rheumatology, University Clinic “Carl-Gustav-Carus”, Dresden, Germany
⨯ -
Frederic Lioté,
Affiliations INSERM, UMR-S 1132, Hospital Lariboisière, Paris, France, University Paris Diderot (UFR de Médecine), Sorbonne Paris Cité, Paris, France
⨯ -
Leo Lu,
Affiliation Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America
⨯ -
Eli A. Stahl,
Affiliation Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America
⨯ -
Hyon K. Choi,
Affiliation Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America
⨯ -
Alexander So,
Affiliation DAL, Service of Rheumatology, Laboratory of Rheumatology, University of Lausanne, CHUV, Nestlé, Lausanne, Switzerland
⨯ - [ ... ],
-
Tony R. Merriman
* E-mail: tony.merriman@otago.ac.nz
Affiliation Department of Biochemistry, University of Otago, Dunedin, New Zealand
⨯ - [ view all ]
- [ view less ]
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets
- Humaira Rasheed,
- Cushla McKinney,
- Lisa K. Stamp,
- Nicola Dalbeth,
- Ruth K. Topless,
- Richard Day,
- Diluk Kannangara,
- Kenneth Williams,
- Malcolm Smith,
- Matthijs Janssen
- Published: January 25, 2016
- https://doi.org/10.1371/journal.pone.0147939